SNAP-8
Cosmetic octapeptide (Acetyl Octapeptide-3) that competitively inhibits SNARE complex formation to reduce neuromuscular junction signaling, decreasing dynamic wrinkle depth — an elongated, potentially more potent version of Argireline.
Quick Facts
| Property | Value |
|---|---|
| Also Known As | Acetyl Octapeptide-3, Acetyl Octapeptide-1, SNAP-8 Peptide, Lipotec SNAP-8 |
| Category | Cosmetic / Topical / Neurotransmitter Inhibitor Peptide |
| Sequence | Acetyl-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2 (octapeptide; N-acetylated) |
| Molecular Weight | ~1075 Da |
| Molecular Formula | C41H68N16O16S |
| PubChem CID | 71587832 |
| Administration | Topical |
| Typical Dose Range | 3-10% in finished formulation |
| Half-Life | N/A (topical, local action) |
| Storage | 2-8C for bulk; room temperature in finished product; protect from light |
| FDA Status | Cosmetic ingredient (INCI listed); NOT a drug — no FDA approval required or sought |
| WADA Status | Not applicable |
Mechanism of Action
SNAP-8 works through the same fundamental mechanism as its parent compound Argireline (Acetyl Hexapeptide-3): competitive inhibition of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) complex. The SNARE complex is a molecular machine essential for synaptic vesicle fusion and neurotransmitter release at the neuromuscular junction.
Under normal physiology, three proteins — SNAP-25 (synaptosomal-associated protein 25 kDa), VAMP/synaptobrevin, and syntaxin — assemble into the SNARE complex, driving vesicle fusion and acetylcholine (ACh) release. Botulinum toxin (Botox) works by cleaving SNAP-25, permanently disabling this machinery. SNAP-8 takes a different approach: its amino acid sequence mimics the N-terminal domain of SNAP-25, allowing it to competitively bind into the SNARE complex and interfere with its assembly. This reduces — but does not eliminate — acetylcholine release at facial neuromuscular junctions, resulting in decreased muscle contraction amplitude and reduced dynamic wrinkle formation (PMID: 33195061).
SNAP-8 is an 8-amino acid elongation of the 6-amino acid Argireline sequence. The additional two residues (Ala-Asp) at the C-terminus are proposed to improve binding affinity to the SNARE complex, potentially increasing potency. In manufacturer-sponsored testing, SNAP-8 at 3% of a 0.05% solution reduced wrinkle depth by up to 38% over 28 days of twice-daily application, with an average reduction of 7.1% (PMID: 33195061).
The key limitation of all topical neurotransmitter-inhibiting peptides, including SNAP-8, is penetration through the stratum corneum. SNAP-8 is hydrophilic and relatively large (~1075 Da), making passive diffusion through the lipophilic skin barrier challenging. Effective delivery requires formulation strategies such as oil-in-water emulsions, microneedle patches, nanoparticle carriers, or penetration enhancers (PMID: 39082657).
Key Research Areas
- Anti-wrinkle efficacy — Split-face studies show up to 38% wrinkle depth reduction with topical SNAP-8 formulations applied twice daily for 28 days (PMID: 33195061)
- SNARE complex inhibition — Competitive binding to SNAP-25 binding site reduces acetylcholine vesicle fusion and release, mimicking Botox mechanism non-invasively
- Advanced delivery systems — Dissolving microneedle patches containing SNAP-8 demonstrate improved penetration and clinical anti-wrinkle efficacy (PMID: 39082657)
- Comparison to Argireline — Elongated 8-amino acid sequence vs. 6-amino acid Argireline; potentially improved SNARE complex binding affinity
Evidence Level Summary
| Evidence Type | Count | Notes |
|---|---|---|
| Human RCTs | 1 | Microneedle delivery split-face RCT (n=24) |
| Human observational | 0 | — |
| Animal in vivo | 0 | — |
| In vitro | 1+ | SNARE complex binding, skin penetration studies |
| Systematic reviews | 0 | None specific to SNAP-8 |
| Narrative reviews | 1 | Cosmeceutical peptides review covering SNAP-8 mechanism and efficacy |
Clinical Applications
- Skin Health — Dynamic wrinkle reduction (expression lines)
- Anti-Aging — Non-invasive alternative to botulinum toxin for facial aging
Protocols Using This Peptide
- Skin Rejuvenation Protocol — Topical anti-wrinkle component
Ageless Peps Products
- AP-SNAP8-Vial — SNAP-8 vial (WC ID 772, DRAFT — not yet published, $120)
Dosing Reference
Research Dosing Ranges (from literature)
| Route | Dose Range | Frequency | Duration | Source |
|---|---|---|---|---|
| Topical | 3-10% in formulation | Twice daily | 28+ days | PMID 33195061 |
| Microneedle patch | As formulated in HA backbone | Overnight application | 28 days | PMID 39082657 |
Cycling
No cycling required. Continuous daily use is recommended. Effects are reversible and cease within weeks of discontinuation (similar to Argireline).
Contraindications & Safety
- Contraindications: Known hypersensitivity to any component
- Common side effects: Rare mild skin irritation at higher concentrations; patch test recommended at 10%
- Drug interactions: No systemic absorption at cosmetic concentrations; no known interactions
- Pregnancy/nursing: Topical peptides generally considered safe at cosmetic concentrations; consult dermatologist
- Special populations: Well-tolerated across skin types; limited data in pediatric populations (not indicated)
Synergistic Combinations
- Argireline + SNAP-8 — Parent and elongated form; can be combined for enhanced SNARE inhibition, though mechanism overlap means diminishing returns
- Syn-ake + SNAP-8 — Complementary mechanisms: SNAP-8 inhibits SNARE complex (presynaptic), Syn-ake blocks nicotinic acetylcholine receptor (postsynaptic). Dual blockade of neuromuscular signaling
- Matrixyl + SNAP-8 — SNARE inhibition (muscle relaxation) + collagen stimulation (ECM repair) for comprehensive anti-aging
- GHK-Cu + SNAP-8 — Copper peptide remodeling + muscle relaxation for synergistic wrinkle reduction
Related Research
| PMID | Title | Year | Study Type |
|---|---|---|---|
| 33195061 | Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy | 2020 | Narrative Review |
| 39082657 | Dissolving Microneedle Patch with Acetyl Octapeptide-3: Clinical Anti-Wrinkle Evaluation | 2024 | RCT |
References
- PMID 33195061 — Comprehensive cosmeceutical peptide review including SNAP-8 mechanism and efficacy data
- PMID 39082657 — Clinical microneedle delivery study with SNAP-8
Related
- Peptide Index
- Condition Index
- Protocol Index
- Argireline — Parent compound (Acetyl Hexapeptide-3, 6 amino acids vs. SNAP-8's 8)
- Syn-ake — Complementary anti-wrinkle mechanism (postsynaptic blockade)
- Matrixyl — Signal peptide for collagen stimulation
#peptide #cosmetic #topical